Biotech and medical tech stocks report significant updates in the race for cancer treatments as cancer rates rise globally

Vancouver, kelowna, and delta, british columbia--(newsfile corp. - november 14, 2024) - investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases a snapshot looking at the advancement of treatments for solid tumors as global cancer incidence rates rise, featuring aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases. according to a recent article in biospace,"the solid tumors market size reached a value of us$ 170.3 billion in 2023.
AEMD Ratings Summary
AEMD Quant Ranking